IL1B and Insulin resistance: When tested in mice, treatment with MCC950 attenuated the increase in body weight induced by an HFD, reduced IL-1β concentrations in adipose tissue, prevented insulin resistance, and reduced airway inflammation induced by obesity [159,160].